Author

A. Carminati

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Baeri· 1 shared A. Lieu· 1 shared A. Prechtel· 1 shared A. Schnepf· 1 shared B. Mari· 1 shared C. Girard· 1 shared C. Lacoux· 1 shared C. Mounier· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Baeri

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Linking rhizosphere processes across scales: Opinion

A. Schnepf, A. Carminati, M. Ahmed, M. Ani, P. Benard, J. Bentz, M. Bonkowski, M. Brax, D. Diehl, P. Duddek, E. Kroener, M. Javaux, M. Landl, E. Lehndorff, E. Lippold, , D. Vetterlein

The paper discusses how multi-scale rhizosphere processes influence plant-scale behavior and presents models that integrate experimental data across scales to predict rhizodeposition and microbial activity.

bioRxiv · Jul 8, 2021Bioengineering

Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma

S. Diazzi, A. Baeri, J. Fassy, M. Lecacheur, O. Marin-Bejar, C. Girard, L. Lefevre, C. Lacoux, M. Irondelle, C. Mounier, M. Truchi, M. Couralet, A. Carminati, I. Berestjuk, F. Larbret, , S. Tartare-Deckert

This study identifies the miR-143/-145 cluster as a driver of therapy-resistant mesenchymal-like phenotype in melanoma and shows that blocking its pro-fibrotic effects enhances MAPK inhibitor efficacy.

bioRxiv · Jul 2, 2021Cancer Biology